Emiliano Escamilla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Emiliano Escamilla has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Aditya R. Jangid
Department of Biological Sciences, California Polytechnic State University, San Luis Obispo, CA 93407, USA
1 shared publication - Andres W. Martinez
Chemistry & Biochemistry Department, California Polytechnic State University, San Luis Obispo, California 93407, United States
1 shared publication - Brittany A. Lore
Department of Biological Sciences, California Polytechnic State University, San Luis Obispo, CA 93407, USA
1 shared publication - E. Brandon Strong
Department of Neurosurgery, University of California, Davis, Sacramento, California
1 shared publication - Nathaniel W. Martinez
Department of Biological Sciences, California Polytechnic State University, San Luis Obispo, CA 93407, USA
1 shared publication - Nicholas J. Tod
Department of Biological Sciences, California Polytechnic State University, San Luis Obispo, CA 93407, USA
1 shared publication
Latest Publications
- Open Access
- 21 August 2019
- Published by MDPI AG in Inventions
- Vol. 4 (3) , 48
Chronometric Quantitation of Analytes in Paper-Based Microfluidic Devices (MicroPADs) via Enzymatic Degradation of a Metastable Biomatrix
The following article summarizes United States Patent Application No. US20180052155A1, titled ‘Assay Devices and Methods’ (filed 16 August 2016, published 22 February 2018). While lateral flow assays (LFAs) have revolutionized point-of-care diagnostics by enabling accurate, inexpensive, and rapid detection of biomarkers, they typically do not provide quantitative results. Hence, there is a significant need for quantitative assays at the point of care. This patent summary describes a novel method of chronometric biomarker quantitation via enzymatic degradation of a metastable gelatin-based biomatrix, principally suited for use in paper-based microfluidic devices (microPADs). This new quantitation mechanism was designed to meet the ASSURED criteria for point-of-care diagnostic devices laid forth by the World Health Organization and may ultimately provide increased access to healthcare, at a significantly reduced cost, around the world.
- 21 August 2019
- Published by MDPI AG in Inventions
- Vol. 4 (3) , 48
Open AccessChronometric Quantitation of Analytes in Paper-Based Microfluidic Devices (MicroPADs) via Enzymatic Degradation of a Metastable Biomatrix
The following article summarizes United States Patent Application No. US20180052155A1, titled ‘Assay Devices and Methods’ (filed 16 August 2016, published 22 February 2018). While lateral flow assays (LFAs) have revolutionized point-of-care diagnostics by enabling accurate, inexpensive, and rapid detection of biomarkers, they typically do not provide quantitative results. Hence, there is a significant need for quantitative assays at the point of care. This patent summary describes a novel method of chronometric biomarker quantitation via enzymatic degradation of a metastable gelatin-based biomatrix, principally suited for use in paper-based microfluidic devices (microPADs). This new quantitation mechanism was designed to meet the ASSURED criteria for point-of-care diagnostic devices laid forth by the World Health Organization and may ultimately provide increased access to healthcare, at a significantly reduced cost, around the world.